Inovaare is proud to be the Diamond Sponsor of the 2024 HICE Annual Conference. We look forward to engaging with you in Indian Wells this December!

HICE
Inovaare listed as a representative vendor in the Gartner® Hype Cycle™ for Healthcare Payers, 2024 - Inovaare Inovaare listed as a representative vendor in the Gartner® Hype Cycle™ for Healthcare Payers, 2024 - Inovaare

Inovaare listed as a representative vendor in the Gartner® Hype Cycle™ for Healthcare Payers, 2024

MILPITAS, Calif., Aug. 27, 2024 /PRNewswire-PRWeb/ — Inovaare Corporation, an industry-leading healthcare compliance and operations management health cloud solutions provider, today announced that it was recognized by Gartner in its report “Hype Cycle for U.S. Healthcare Payers, 2024” as a Sample Vendor for the LLMs for Healthcare Payers and Consumer-Centric Health Products categories. Gartner has identified both as “Transformational” within their Innovation Triggers slope.

“These technologies and approaches have the potential to deliver transformative business benefits by driving business and operating model changes,” write Gartner analysts Mandi Bishop, Austynn Eubank and Connie Salgy in the report. “These capabilities build on modernization efforts and promise high strategic value, but the organization must be prepared to embrace disruptive change to realize the full potential.”

The Hype Cycle for Healthcare Payers, 2024 provides critical input for strategic planning by tracking the maturity level and adoption rate of payer technologies and deployment approaches. According to the report, “This Hype Cycle provides critical input for strategic planning by tracking the maturity level and adoption rate of payer technologies and deployment approaches. U.S. healthcare Payer CIOs should use this to plan new and manage existing investments for business optimization and transformation.”

LLMs for Healthcare Payers

LLMs for Healthcare Payers as a technology category has been mentioned in the “Innovation Trigger” phase in the Hype Cycle with a “Transformational” Benefit Rating, which indicates this technology enables new ways of doing business across industries that will result in major shifts in industry dynamics.

Inovaare’s UsherAI and customer-centric solutions, built on the Inovaare Health Cloud, help Payers undertake their journey towards these revenue and cost objectives by accelerating their digital transformation to improve Total Experiences and member outcomes. These generative AI algorithms are trained on large volumes of unlabeled textual data, which can accomplish a large scope of tasks, such as: content generation, content summarization, search, language translation and conversational chat for healthcare Payer industry use cases.

“We’re excited to be identified as a Sample Vendor in the Gartner Hype Cycle report for U.S. Healthcare Payers,” said Pravat Rout, CEO of Inovaare. “We feel Gartner recognition is a testament to our health cloud platform’s ability to help clients accelerate digital innovation at scale. We thank Gartner for their thoughtful analysis and look forward to working with Payers to help them achieve their digital transformation goals.”

To learn more about Inovaare’s solutions, request a demo or speak to our team of healthcare industry experts, contact us today. For a limited time, Inovaare is offering access to this report at: https://bit.ly/4fXg1BZ

*Gartner, “Hype Cycle for Healthcare Payers, 2024”, Mandi Bishop, Austynn Eubank, Connie Salgy, July 29, 2024.

GARTNER and HYPE CYCLE are registered trademarks and service marks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation.

Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.